Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$82,482,409
+$19,660,279 QoQ
Shares Held
68,768
+0.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
3.11%
of 13F equity value
Holder Rank
#418
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mutual Advisors, LLC holds $138,410,834 across 12 Drug Manufacturers - General names. LLY ranks #1 (59.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
68,768 | $82,482,409 | |
| 2 | JNJ |
Johnson & Johnson
|
56,927 | $14,457,750 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,606 | $10,100,871 | |
| 4 | ABBV |
AbbVie Inc.
|
33,603 | $8,455,858 | |
| 5 | PFE |
Pfizer Inc
|
250,040 | $6,020,963 | |
| 6 | AMGN |
Amgen Inc
|
13,560 | $4,910,347 | |
| 7 | NVO |
Novo Nordisk A S
|
72,417 | $3,471,670 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
22,689 | $2,866,528 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $82,482,409 | 68,768 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $62,822,130 | 68,302 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $70,723,622 | 65,809 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $50,170,302 | 65,754 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $49,726,998 | 63,791 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $52,414,726 | 63,463 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $48,978,768 | 63,444 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $54,541,124 | 61,563 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $55,689,923 | 61,510 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $48,698,740 | 62,598 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $7,228,790 | 12,401 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $5,534,050 | 10,303 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,965,894 | 12,721 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $3,750,146 | 10,920 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $3,599,499 | 9,839 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $3,062,447 | 9,471 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $3,172,914 | 9,786 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,952,474 | 10,310 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,842,027 | 10,289 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,493,953 | 10,794 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,282,117 | 9,943 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,847,276 | 9,888 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,520,404 | 9,005 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,503,883 | 10,160 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $1,701,397 | 10,363 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,354,739 | 9,766 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||